CG:603739 Qingdao Vland Biotech Co.Ltd

Qingdao Vland Biotech INC. engages in the research and development of enzymes, probiotics, and animal vaccines and health products. It offers animal feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated poultry, and swine vaccines, as well as antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens. It serves agriculture, animal husbandry, textile, paper making, household cleaning and detergents, food, biofuel, environmental protection, and other industries. The company was founded in 2005 and is headquartered in Qingdao, China. Qingdao Vland Biotech INC. is a subsidiary of Qingdao Kangdien Industrial Co., Ltd.

17.31 CNY
As of 01/28/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  China
IPO date:  02/21/2019
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   4,199,735,808 CNY
Current dividend yield:   0.84%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy